Asset Details
Do you wish to reserve the book?
Protective Effects of Luffa cylindrica Leaf Infusion Against Cisplatin and CCl4‐Induced Hepatorenal Toxicity in Rats: Biochemical, Histopathological, and Molecular Docking Analysis
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Protective Effects of Luffa cylindrica Leaf Infusion Against Cisplatin and CCl4‐Induced Hepatorenal Toxicity in Rats: Biochemical, Histopathological, and Molecular Docking Analysis
Do you wish to request the book?
Protective Effects of Luffa cylindrica Leaf Infusion Against Cisplatin and CCl4‐Induced Hepatorenal Toxicity in Rats: Biochemical, Histopathological, and Molecular Docking Analysis
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Protective Effects of Luffa cylindrica Leaf Infusion Against Cisplatin and CCl4‐Induced Hepatorenal Toxicity in Rats: Biochemical, Histopathological, and Molecular Docking Analysis
2026
Overview
This study demonstrated the antioxidant potential of Luffa cylindrica leaf infusion (LLI) in alleviating oxidative damage induced by cisplatin and carbon tetrachloride (CCl4) in Wistar rats. Phytochemical analysis confirmed the presence of bioactive compounds, such as protocatechuic acid (PCA; 5.83 mg/g DW), naringenin (5.54 mg/g DW), chlorogenic acid (CA; 4.90 mg/g DW), and ascorbic acid (4.87 mg/g DW). In vivo results showed that LLI administration by gavage significantly improved kidney and liver functions, particularly at a dose of 40 mg/kg, as evidenced by serum biochemical markers for both organs. Furthermore, LLI pretreatment restored superoxide dismutase (SOD) and CAT activity while reducing MDA levels, indicating a protective effect against oxidative stress. Histopathological analysis revealed that LLI treatment reduced structural damage in liver and kidney tissues, confirming its protective capacity. Molecular docking studies revealed that naringenin, PCA, and CA exhibit strong binding affinities to SOD, potentially enhancing its activity synergistically. These findings suggest that LLI, rich in natural antioxidants, may serve as a promising therapeutic candidate for mitigating oxidative stress–induced organ damage, warranting further investigation in clinical settings.
